The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.
The Alzheimer's Disease Centers' Uniform Data Set (UDS): The Neuropsychologic Test Battery
Open accessAbstract
The neuropsychologic test battery from the Uniform Data Set (UDS) of the Alzheimer's Disease Centers (ADC) program of the National Institute on Aging consists of brief measures of attention, processing speed, executive function, episodic memory, and language. This paper describes development of the battery and preliminary data from the initial UDS evaluation of 3268 clinically cognitively normal men and women collected over the first 24 months of utilization. The subjects represent a sample of community-dwelling, individuals who volunteer for studies of cognitive aging. Subjects were considered "clinically cognitively normal" based on clinical assessment, including the Clinical Dementia Rating scale and the Functional Assessment Questionnaire. The results demonstrate performance on tests sensitive to cognitive aging and to the early stages of Alzheimer disease in a relatively well-educated sample. Regression models investigating the impact of age, education, and sex on test scores indicate that these variables will need to be incorporated in subsequent normative studies. Future plans include: (1) determining the psychometric properties of the battery; (2) establishing normative data, including norms for different ethnic minority groups; and (3) conducting longitudinal studies on cognitively normal subjects, individuals with mild cognitive impairment, and individuals with Alzheimer disease and other forms of dementia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mild Cognitive Impairment: Clinical Characterization and Outcome
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980
The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia
Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A., & Gornbein, J. (1994) · Neurology · doi:10.1212/wnl.44.12.2308 · Cited by 7,568
Self-citationSheikh (1986) · doi:10.1300/j018v05n01_09 · Cited by 7,236
The processing-speed theory of adult age differences in cognition
Salthouse, T. A. (1996) · Psychological Review · doi:10.1037/0033-295x.103.3.403 · Cited by 5,902 · cited 1×
“Aging itself is associated with a reduction in the immediate span of attention [54], slowed processing speed [55,56], and a reduction in the amount of information that can be learned and retrieved over time [17,57–59].”
The Mini‐Mental State Examination: A Comprehensive Review
Tombaugh, T. N., & McIntyre, N. J. (1992) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1992.tb01992.x · Cited by 5,152
Current concepts in mild cognitive impairment
Petersen, R. C., Doody, R., Kurz, A., Mohs, R. C., Morris, J. C., Rabins, P. V., Ritchie, K., Rossor, M., Thal, L., & Winblad, B. (2001) · Archives of Neurology · doi:10.1001/archneur.58.12.1985 · Cited by 4,781
Self-citationKaplan, E., Goodglass, H., Weıntraub, S., & Segal, O. (2001) · Medical Entomology and Zoology · Cited by 4,378
Moms, J. C., Heyman, A., Mohs, R. C., Hughes, J. P., van Belle, G., Fillenbaum, G., Mellits, E. D., & Clark, C. (1989) · Neurology · doi:10.1212/wnl.39.9.1159 · Cited by 4,130
The Halstead-Reitan neuropsychological test battery: Theory and clinical interpretation
Reitan, R. M., & Wolfson, D. E. (1993) · Medical Entomology and Zoology · Cited by 3,854
Psychological Assessment Resources
Abidin, R. R. (1995) · Medical Entomology and Zoology · Cited by 3,147
Research works printed but not linked: 4
- Ferris, 1997, Assessing cognition in Alzheimer disease research, Alzheimer Dis Assoc Disord, 11, 45
- Albert, 2000, Early detection of Alzheimer's disease using neuropsychological testing, Neurobiol Aging, 21, S73, 10.1016/S0197-4580(00)82550-6 · doi:10.1016/s0197-4580(00)82550-6
- Goodglass, 2001, Boston Diagnostic Aphasia Examination Third Edition (BDAE-3)
- Chapman, 1997, Prose recall in dementia. A comparison of delay intervals, Arch Neurol, 54, 1501, 10.1001/archneur.1997.00550240053012 · doi:10.1001/archneur.1997.00550240053012
Cited by
Blood-brain barrier breakdown in the aging human hippocampus
Montagne, A., Barnes, S. R., Sweeney, M. D., Halliday, M. R., Sagare, A. P., Zhao, Z., Toga, A. W., Jacobs, R. E., Liu, C. Y., Amezcua, L., et al. (2015) · Neuron · doi:10.1016/j.neuron.2014.12.032 · Cited by 2,102
Self-citationAPOE4 leads to blood–brain barrier dysfunction predicting cognitive decline
Montagne, A., Nation, D. A., Sagare, A. P., Barisano, G., Sweeney, M. D., Chakhoyan, A., Pachicano, M., Joe, E., Nelson, A. R., D’Orazio, L. M., et al. (2020) · Nature · doi:10.1038/s41586-020-2247-3 · Cited by 1,281
Self-citationSex modifies the APOE ‐related risk of developing Alzheimer disease
Altmann, A., Tian, L., Henderson, V. W., Greicius, M. D., & Alzheimer's Disease Neuroimaging Initiative Investigators (2014) · Annals of Neurology · doi:10.1002/ana.24135 · Cited by 891
Toledo, J. B., Arnold, S. E., Raible, K., Brettschneider, J., Xie, S. X., Grossman, M., Monsell, S. E., Kukull, W. A., & Trojanowski, J. Q. (2013) · Brain · doi:10.1093/brain/awt188 · Cited by 849
Self-citationLaMontagne, P. J., Benzinger, T. L., Morris, J. C., Keefe, S., Hornbeck, R., Xiong, C., Grant, E., Hassenstab, J., Moulder, K., Vlassenko, A. G., et al. (2019) · medRxiv · doi:10.1101/2019.12.13.19014902 · Cited by 779
“Participants received an I.V. bolus injection of 5 mCi of [ 18 F]FDG followed by a dynamic 60min (consisting of 24 x 5 sec frames, 9 x 20 sec frames, 10 x 1 min frames and 9 x 5 min frames) PET acquisition.”
Self-citationBondi, M. W., Initiative, F. T. A. D. N., Edmonds, E. C., Jak, A. J., Clark, L. R., Delano-Wood, L., McDonald, C. R., Nation, D. A., Libon, D. J., Au, R., et al. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-140276 · Cited by 772
“Each measure was converted to an age-corrected standard score using published normative data: Mayo Older Americans Normative Study data (n = 530; [36]) for the Rey AVLT and National Alzheimer’s Coordinating Center normative data (n = 3,286; [37, 38]) for the remaining neuropsychological measures.”
Self-citationWeintraub, S., Besser, L., Dodge, H. H., Teylan, M., Ferris, S., Goldstein, F. C., Giordani, B., Kramer, J., Loewenstein, D., Marson, D., et al. (2018) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000223 · Cited by 671
Self-citationGOLLAN, T. H., WEISSBERGER, G. H., RUNNQVIST, E., MONTOYA, R. I., & CERA, C. M. (2012) · Bilingualism: Language and Cognition · doi:10.1017/s1366728911000332 · Cited by 527
Marshall, G. A., Rentz, D. M., Frey, M. T., Locascio, J. J., Johnson, K. A., Sperling, R. A., & Initiative, A. D. N. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2010.04.005 · Cited by 437
Sachdev, P. S., Lipnicki, D. M., Kochan, N. A., Crawford, J. D., Thalamuthu, A., Andrews, G., Brayne, C., Matthews, F. E., Stephan, B. C. M., Lipton, R. B., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0142388 · Cited by 380
Assessment of Racial Disparities in Biomarkers for Alzheimer Disease
Morris, J. C., Schindler, S. E., McCue, L. M., Moulder, K. L., Benzinger, T. L. S., Cruchaga, C., Fagan, A. M., Grant, E., Gordon, B. A., Holtzman, D. M., et al. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2018.4249 · Cited by 370
Self-citationGut microbiome composition may be an indicator of preclinical Alzheimer’s disease
Ferreiro, A. L., Choi, J., Ryou, J., Newcomer, E. P., Thompson, R., Bollinger, R. M., Hall-Moore, C., Ndao, I. M., Sax, L., Benzinger, T. L. S., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abo2984 · Cited by 356
Self-citationIn vivo radioligand binding to translocator protein correlates with severity of Alzheimer’s disease
Kreisl, W. C., Lyoo, C. H., McGwier, M., Snow, J., Jenko, K. J., Kimura, N., Corona, W., Morse, C. L., Zoghbi, S. S., Pike, V. W., et al. (2013) · Brain · doi:10.1093/brain/awt145 · Cited by 350
“The neuropsychological testing battery was adapted from the Uniform Data Set to be consistent with batteries used in previous studies that stratify patients into MCI and Alzheimer’s disease cohorts (Weintraub et al ., 2009”
MethodQuantitative classification of primary progressive aphasia at early and mild impairment stages
Mesulam, M. M., Wieneke, C., Thompson, C., Rogalski, E., & Weintraub, S. (2012) · Brain · doi:10.1093/brain/aws080 · Cited by 347
Self-citationDeiner, S., Luo, X., Lin, H.-M., Sessler, D. I., Saager, L., Sieber, F. E., Lee, H. B., Sano, M., and the Dexlirium Writing Group, Jankowski, C., et al. (2017) · JAMA Surgery · doi:10.1001/jamasurg.2017.1505 · Cited by 333
Orr, M., Gonzales, M., Garbarino, V., Kautz, T., Palavicini, J., Lopez-Cruzan, M., Dehkordi, S. K., Mathews, J., Zare, H., Xu, P., et al. (2023) · doi:10.21203/rs.3.rs-2809973/v1 · Cited by 319
Knopman, D. S., Gottesman, R. F., Sharrett, A. R., Wruck, L. M., Windham, B. G., Coker, L., Schneider, A. L. C., Hengrui, S., Alonso, A., Coresh, J., et al. (2016) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2015.12.002 · Cited by 313
Structural brain differences and cognitive functioning related to body mass index in older females
Walther, K., Birdsill, A. C., Glisky, E. L., & Ryan, L. (2010) · Human Brain Mapping · doi:10.1002/hbm.20916 · Cited by 290
Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trial
Gonzales, M. M., Garbarino, V. R., Kautz, T. F., Palavicini, J. P., Lopez-Cruzan, M., Dehkordi, S. K., Mathews, J. J., Zare, H., Xu, P., Zhang, B., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02543-w · Cited by 334
Acoustic Enhancement of Sleep Slow Oscillations and Concomitant Memory Improvement in Older Adults
Papalambros, N. A., Santostasi, G., Malkani, R. G., Braun, R., Weintraub, S., Paller, K. A., & Zee, P. C. (2017) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2017.00109 · Cited by 259
Autosomal Recessive Causes Likely in Early-Onset Alzheimer Disease
Wingo, T. S. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.221 · Cited by 265
What did you do yesterday? A meta-analysis of sex differences in episodic memory.
Asperholm, M., Högman, N., Rafi, J., & Herlitz, A. (2019) · Psychological Bulletin · doi:10.1037/bul0000197 · Cited by 182
APOE ε2 is associated with milder clinical and pathological Alzheimer disease
Serrano‐Pozo, A., Qian, J., Monsell, S. E., Betensky, R. A., & Hyman, B. T. (2015) · Annals of Neurology · doi:10.1002/ana.24369 · Cited by 176
An explainable machine learning approach for Alzheimer’s disease classification
Alatrany, A. S., Khan, W., Hussain, A., Kolivand, H., & Al-Jumeily, D. (2024) · Scientific Reports · doi:10.1038/s41598-024-51985-w · Cited by 172
Qian, J., Wolters, F. J., Beiser, A., Haan, M., Ikram, M. A., Karlawish, J., Langbaum, J. B., Neuhaus, J. M., Reiman, E. M., Roberts, J. S., et al. (2017) · PLOS Medicine · doi:10.1371/journal.pmed.1002254 · Cited by 169
Unobtrusive measurement of daily computer use to detect mild cognitive impairment
Kaye, J., Mattek, N., Dodge, H. H., Campbell, I., Hayes, T., Austin, D., Hatt, W., Wild, K., Jimison, H., & Pavel, M. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.01.011 · Cited by 145
Current limitations of neuropsychological tests and assessment procedures
Howieson, D. (2019) · The Clinical Neuropsychologist · doi:10.1080/13854046.2018.1552762 · Cited by 143
“For diseases that produce a predictable cognitive profile, some test batteries have been developed: Alzheimer’s disease (Verma et al., 2015; Weintraub et al., 2009), Huntington disease (Stout et al., 2014), multiple sclerosis (Benedict et al., 2002, 2012), frontal injuries (Dubois, Slachevsky,…”
Boise, L., Wild, K., Mattek, N., Ruhl, M., Dodge, H. H., & Kaye, J. (2013) · Gerontechnology · doi:10.4017/gt.2013.11.3.001.00 · Cited by 139
“(iii) Are there differences between survey respondents with mild cognitive impairment and those with intact cognition in their attitudes towards”
Salinas, J., Beiser, A. S., Samra, J. K., O'Donnell, A., DeCarli, C. S., Gonzales, M. M., Aparicio, H. J., & Seshadri, S. (2022) · Neurology · doi:10.1212/wnl.0000000000200039 · Cited by 127
Self-citationBrouillette, R. M., Foil, H., Fontenot, S., Correro, A., Allen, R., Martin, C. K., Bruce-Keller, A. J., & Keller, J. N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065925 · Cited by 113
APOE2 eases cognitive decline during Aging: Clinical and preclinical evaluations
Shinohara, M., Kanekiyo, T., Yang, L., Linthicum, D., Shinohara, M., Fu, Y., Price, L., Frisch‐Daiello, J. L., Han, X., Fryer, J. D., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24628 · Cited by 111
Language and behavior domains enhance the value of the clinical dementia rating scale
Knopman, D. S., Weintraub, S., & Pankratz, V. S. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2010.12.006 · Cited by 105
Tau Oligomer–Containing Synapse Elimination by Microglia and Astrocytes in Alzheimer Disease
Taddei, R. N., Perbet, R., Mate de Gerando, A., Wiedmer, A. E., Sanchez-Mico, M., Connors Stewart, T., Gaona, A., Melloni, A., Amaral, A. C., Duff, K., et al. (2023) · JAMA Neurology · doi:10.1001/jamaneurol.2023.3530 · Cited by 110
Long-Term Multivitamin Supplementation and Cognitive Function in Men: A Randomized Trial
Grodstein, F., O’Brien, J., Kang, J. H., Dushkes, R., Cook, N. R., Okereke, O., Manson, J. E., Glynn, R. J., Buring, J. E., Gaziano, J. M., et al. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-12-201312170-00006 · Cited by 110
Chen, Y., Denny, K. G., Harvey, D., Farias, S. T., Mungas, D., DeCarli, C., & Beckett, L. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.07.151 · Cited by 98
Self-citationPsychological treatments for depression and anxiety in dementia and mild cognitive impairment
Orgeta, V., Leung, P., del-Pino-Casado, R., Qazi, A., Orrell, M., Spector, A. E., & Methley, A. M. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009125.pub3 · Cited by 103
Risk factors and global cognitive status related to brain arteriolosclerosis in elderly individuals
Ighodaro, E. T., Abner, E. L., Fardo, D. W., Lin, A.-L., Katsumata, Y., Schmitt, F. A., Kryscio, R. J., Jicha, G. A., Neltner, J. H., Monsell, S. E., et al. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x15621574 · Cited by 98
Self-citationLau, K. M., Parikh, M., Harvey, D. J., Huang, C.-J., & Farias, S. T. (2015) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617715000818 · Cited by 89
APOE2 is associated with longevity independent of Alzheimer’s disease
Shinohara, M., Kanekiyo, T., Tachibana, M., Kurti, A., Shinohara, M., Fu, Y., Zhao, J., Han, X., Sullivan, P. M., Rebeck, G. W., et al. (2020) · eLife · doi:10.7554/elife.62199 · Cited by 82
Neocortical origin and progression of gray matter atrophy in nonamnestic Alzheimer's disease
Phillips, J. S., Da Re, F., Dratch, L., Xie, S. X., Irwin, D. J., McMillan, C. T., Vaishnavi, S. N., Ferrarese, C., Lee, E. B., Shaw, L. M., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.11.008 · Cited by 74
Using genetics to enable studies on the prevention of Alzheimer's disease
Crenshaw, D. G., Gottschalk, W. K., Lutz, M. W., Grossman, I., Saunders, A. M., Burke, J. R., Welsh-Bohmer, K. A., Brannan, S. K., Burns, D. K., & Roses, A. D. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.222 · Cited by 70
Preclinical AD Workgroup staging: Pathological correlates and potential challenges
Jicha, G. A., Abner, E. L., Schmitt, F. A., Kryscio, R. J., Riley, K. P., Cooper, G. E., Stiles, N., Mendiondo, M. S., Smith, C. D., Van Eldik, L. J., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.02.018 · Cited by 71
Neuropsychological changes in asymptomatic persons with Alzheimer disease neuropathology
Monsell, S. E., Mock, C., Hassenstab, J., Roe, C. M., Cairns, N. J., Morris, J. C., & Kukull, W. (2014) · Neurology · doi:10.1212/wnl.0000000000000650 · Cited by 71
Self-citationMorris, J. C., Weiner, M., Xiong, C., Beckett, L., Coble, D., Saito, N., Aisen, P. S., Allegri, R., Benzinger, T. L. S., Berman, S. B., et al. (2022) · Brain · doi:10.1093/brain/awac181 · Cited by 68
Self-citationDong, J. W., Jelescu, I. O., Ades-Aron, B., Novikov, D. S., Friedman, K., Babb, J. S., Osorio, R. S., Galvin, J. E., Shepherd, T. M., & Fieremans, E. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.01.009 · Cited by 70
Scott, E. P., Sorrell, A., & Benitez, A. (2019) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617719000614 · Cited by 69
“Participants completed study procedures on the same day, which included the neuropsychological battery of the National Alzheimer’s Coordinating Centers’ Uniform Data Set (Shirk et al., 2011; Weintraub et al., 2009), followed by the NIHTB-CB, and brain MRI.”
MethodRovner, B. W., Casten, R. J., Hegel, M. T., & Leiby, B. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2018.2513 · Cited by 64
Roses, A. D., Lutz, M. W., Crenshaw, D. G., Grossman, I., Saunders, A. M., & Gottschalk, W. K. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.10.009 · Cited by 63
“2 illustrates stratification of the age of cognitive impairment by 523 genotype in which case status is determined clinically during an ongoing prospective study conducted by the Joseph and Kathleen Bryan Alzheimer’s Disease Research Center using carefully applied, standardized, and validated neuropsychological tests…”
MethodBoeve, B., Bove, J., Brannelly, P., Brushaber, D., Coppola, G., Dever, R., Dheel, C., Dickerson, B., Dickinson, S., Faber, K., et al. (2020) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.06.4947 · Cited by 61
Self-citationVidoni, E. D., Perales, J., Alshehri, M., Giles, A.-M., Siengsukon, C. F., & Burns, J. M. (2019) · Journal of Geriatric Physical Therapy · doi:10.1519/jpt.0000000000000172 · Cited by 61
Psychometric properties of the Brazilian version of Pfeffer's Functional Activities Questionnaire
Assis, L. D. O., de Paula, J. J., Assis, M. G., de Moraes, E. N., & Malloy-Diniz, L. F. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00255 · Cited by 54
Dodge, H. H., Goldstein, F. C., Wakim, N. I., Gefen, T., Teylan, M., Chan, K. C. G., Kukull, W. A., Barnes, L. L., Giordani, B., Hughes, T. M., et al. (2020) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1002/trc2.12103 · Cited by 54
Self-citationAssociation of vascular brain injury, neurodegeneration, amyloid, and cognitive trajectory
Han, J. W., Maillard, P., Harvey, D., Fletcher, E., Martinez, O., Johnson, D. K., Olichney, J. M., Farias, S. T., Villeneuve, S., Jagust, W., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000010531 · Cited by 49
Self-citationRisk of dementia and mild cognitive impairment among older adults in same‐sex relationships
Perales‐Puchalt, J., Gauthreaux, K., Flatt, J., Teylan, M. A., Resendez, J., Kukull, W. A., Chan, K. C. G., Burns, J., & Vidoni, E. D. (2019) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5092 · Cited by 47
Self-citationDifferences in cognitive impairment in primary age-related tauopathy versus Alzheimer disease
Besser, L. M., Mock, C., Teylan, M. A., Hassenstab, J., Kukull, W. A., & Crary, J. F. (2019) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nly132 · Cited by 45
Self-citationCarroll, J. E., Nakamura, Z. M., Small, B. J., Zhou, X., Cohen, H. J., Ahles, T. A., Ahn, J., Bethea, T. N., Extermann, M., Graham, D., et al. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.22.00406 · Cited by 37
A genetics-based biomarker risk algorithm for predicting risk of Alzheimer's disease
Lutz, M. W., Sundseth, S. S., Burns, D. K., Saunders, A. M., Hayden, K. M., Burke, J. R., Welsh‐Bohmer, K. A., Roses, A. D., & Initiative, A. D. N. (2016) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2015.12.002 · Cited by 30
Kao, P. F., Banigan, M. G., Vanderburg, C. R., McKee, A. C., Polgar, P. R., Seshadri, S., & Delalle, I. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31825d06b7 · Cited by 31
“These tests cover all major cognitive domains, including most tests from the Alzheimer Disease Center’s Uniform Data Set (30, 31), and are composed of multiple tests measuring related cognitive domains of premorbid vocabulary, verbal memory, visuospatial memory, new learning, abstraction, attention and executive funct…”
MethodCognitive Indicators of Preclinical Behavioral Variant Frontotemporal Dementia in MAPT Carriers
Cheran, G., Wu, L., Lee, S., Manoochehri, M., Cines, S., Fallon, E., Lynch, T., Heidebrink, J., Paulson, H., Goldman, J., et al. (2019) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617718001005 · Cited by 29
“0 was used to compute Z-scores of measures for which normative data was available (Shirk et al., 2011; Weintraub et al., 2009).”
InfluentialAge-at-Onset and APOE -Related Heterogeneity in Pathologically Confirmed Sporadic Alzheimer Disease
Smirnov, D. S., Galasko, D., Hiniker, A., Edland, S. D., & Salmon, D. P. (2021) · Neurology · doi:10.1212/wnl.0000000000011772 · Cited by 25
Self-citationPelclova, D., Urban, P., Fenclova, Z., Vlckova, S., Ridzon, P., Kupka, K., Meckova, Z., Bezdicek, O., Navratil, T., Rosmus, J., et al. (2018) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12899 · Cited by 18
Hausman, H. K., Alexander, G. E., Cohen, R., Marsiske, M., DeKosky, S. T., Hishaw, G. A., O'Shea, A., Kraft, J. N., Dai, Y., Wu, S., et al. (2023) · Brain Stimulation · doi:10.1016/j.brs.2023.05.021 · Cited by 13
Chen, C. D., Ponisio, M. R., Lang, J. A., Flores, S., Schindler, S. E., Fagan, A. M., Morris, J. C., & Benzinger, T. L. S. (2023) · Journal of Alzheimer’s Disease · doi:10.3233/jad-230032 · Cited by 10
Self-citation
Metadata
- Authors
- Weintraub, S., Salmon, D., Mercaldo, N., Ferris, S., Graff-Radford, N. R., Chui, H., Cummings, J., DeCarli, C., Foster, N. L., Galasko, D., Peskind, E., Dietrich, W., Beekly, D. L., Kukull, W. A., & Morris, J. C.
- Venue
- Alzheimer Disease & Associated Disorders
- Published
- 2009-04
- Volume
- 23
- Issue
- 2
- Pages
- 91-101
- ISSN
- 0893-0341 (ISSN-L)
- OpenAlex
- W2172263413
- Cited by
- 888
- References
- 97
- FWCI
- 11.63
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.